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Abstract 
Background: Cow’s milk allergy (CMA) is a common disease in infancy. Early environmental factors are likely to con-
tribute to CMA. It is known that epigenetic gene regulation can be altered by environmental factors. We have set up a 
proof of concept study, aiming to detect epigenetic associations specific with CMA.
Methods: We studied children from the Dutch EuroPrevall birth cohort study (N = 20 CMA, N = 23 controls, N = 10 
tolerant boys), age and gender matched. CMA was challenge proven. Bisulfite converted DNA (blood) was analyzed 
using the 450K infinium DNA-methylation array. Four groups (combined, girls, boys and tolerant boys) were analysed 
between CMA and controls. Statistical analysis and pathway-analysis were performed in “R” using IMA, Minfi and the 
global-test package. Differentially methylated regions in DHX58, ZNF281, EIF42A and HTRA2 genes were validated by 
quantitative amplicon sequencing (ROCHE 454®).
Results: General hypermethylation was found in the CMA group compared to control children, while this effect was 
absent in the tolerant group. Methylation differences were, among others, found in regions of DHX58, ZNF281, EIF42A 
and HTRA2 genes. Several of these genes are known to be involved in immunological pathways and associated with 
other allergies.
Conclusion: We show that epigenetic associations are involved in CMA. Although, the statistical power of our study 
is limited and our sample was based on whole blood, we were still able to detect feasible loci and pathways. Therefore 
our findings might contribute to future diagnostic or therapeutic interventions for specific CMA. Further studies have 
to confirm the findings of our study.
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Background
Cow’s milk allergy
Cow’s milk allergy (CMA) is a common food allergy in 
young children. Accurate data on the worldwide inci-
dences on CMA is still lacking because of discrepancies 
between self-reported and proper diagnosed allergy. A 
recent European study describes an incidence of CMA 
of 0.74  % [1–3]. CMA has a heterogeneous clinical 
presentation, with a low to moderate estimated herit-
ability of 15 % compared to other (food) allergies [4, 5]. 
Accumulating evidence in the development of allergic 
diseases suggest involvement of different pre- and post-
natal environmental factors, like gut-microbiota, matu-
ration of the immune-system and epicutaneous allergen 
sensitization, but also a parent-of-origin factor [4, 6–8]. 
Young children are likely to develop tolerance for cow’s 
milk protein (CMP) within a few years [4, 9]. However, 
infants who suffered from CMA in their early childhood 
have an increased risk to develop other allergic diseases 
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(Epi)genetic component of food allergy
Complex diseases are characterized by a considerable 
heterogenic phenotype, genetic aberrations but also 
include gene-environment interactions. Reports on herit-
ability estimations for food allergy (FA) range from 15 % 
for milk to 82 % for peanut allergy [5, 14]. Some of these 
reported heritability estimates differ largely between 
study populations. Whether this is due to study design, 
geographic or ethnic background or involvement of dif-
ferent environmental factors is not clear [7, 14]. Several 
environmental components like maternal lifestyle, diet, 
stress and hygiene, have been suggested to be involved 
in food allergies [14–18]. Furthermore, accumulating 
evidence suggest the prevalence of FA in well-developed 
countries has been increasing over the last decades. 
Whether this increase is truly occurring is still under 
debate due to limited amount of comparative data. [19, 
20] Genetic selection or genetic drift both are relative 
slow processes and generally occur in isolated popula-
tions, therefore it is highly unlikely that the suggested 
increase of FA is caused by genetic changes or drift 
within these populations. These observations favour the 
possibility that an epigenetic component is involved in 
the expression of FA and CMA.
Allergy with respect to gender
The role of gender and sex hormones in relation to the 
expression of allergy has been studied in epidemiologi-
cal surveys. The distribution between genders is greatly 
skewed with regard to the expression of asthma before 
and after puberty [21, 22]. In general, allergy is more 
prevalent in boys before puberty, while after puberty 
allergies are more prevalent in girls. Reports on differ-
ences between genders suffering from specific food aller-
gies are however inconsistent [6]. Especially, the studies 
based on self-reported allergy questionnaires and studies 
based on a food challenge (the gold standard) show dif-
ferent outcomes [6]. For CMA, differences in prevalence 
between genders are still under debate [23, 24].
In this pilot case–control study, we investigated if (1) 
epigenetic differences can be shown between children 
with proven CMA and healthy controls, (2) if epigenetic 
differences alter upon obtaining cow’s milk protein toler-
ance and (3) whether epigenetic differences are reflected 
by phenotypic differences with regard to gender in the 
CMA population.
Methods
Dutch EuroPrevall birth cohort study
All children were participating in the Dutch Euro-
Prevall birth cohort study. The EuroPrevall study has 
been described in detail previously [25, 26]. In summary, 
children were included around birth and standardized 
measurements were performed by questionnaires until 
2.5  years of age. All children with symptoms sugges-
tive of CMA underwent, among others, serum specific 
IgE (sIgE) measurement (Phadia Diagnostics, Uppsala, 
Sweden) and a double blind placebo controlled food 
challenge (DBPCFC). sIgE-values <0.35 kU/L, were con-
sidered negative. Healthy control children were selected 
from the entire Dutch cohort. Controls had no symptoms 
suggestive of any food allergy nor suffered from atopic 
dermatitis. In children with CMA and healthy controls, 
an attempt was made to obtain one full blood sample 
(EDTA KE 2.6  mL Monovette, Sarstedt BV, Etten-Leur, 
Netherlands) for DNA-isolation, besides the blood used 
for sIgE measurement. The Medical Ethics Commit-
tee of the Academic Medical Hospital (METC 06/005) 
approved the Dutch EuroPrevall Birth Cohort Study, 
including (epi) genetic studies. Written informed con-
sent, both for the study and for the epigenetic study, were 
obtained from both parents of each child, unless only one 
of them had parental rights.
Patient characteristics were analysed with t test 
(Mann–Whitney U test when data was not normally 
distributed) for continuous parameters. Chi square test 
was used for categorical variables and Chi square test 
for trend for multiple categories categorical variables. P 
values <0.05 were considered significant. SPSS version 
20 was used (IBM SPSS Statistics for Windows, Armonk, 
NY).
CMA diagnosis
DBPCFC is the gold standard for diagnosing CMA and 
the challenge of choice according to the study protocol 
[25–27]. The DBPCFC has been described in detail previ-
ously [28]. In summary, the child receives cow’s milk pro-
tein (CMP) free formula with added CMP (active day) or 
the same CMP free formula without the added CMP (pla-
cebo day) in increasing doses, double blinded, in a ran-
dom order, on two different days. All children suspected 
of CMA were challenged with a DBPCFC. DBPCFC was 
repeated annually until the child was tolerant for CMP 
[25]. Meaning, the DBPCFC was negative and/or the 
child was consuming CMP regularly without symptoms.
Samples selected for epigenetic analysis
DNA samples of 20 children with proven and active 
CMA at the time of blood drawing were selected. Sam-
ples of healthy controls (N =  20) were gender matched 
with the 20 CMA-samples. Also ten DNA samples were 
selected of “tolerant boys”. These boys had proven CMA, 
but who were already CMP-tolerant at DNA-sampling. 
For the tolerant-children only boys were included, due to 
the limited availability of samples of tolerant girls. Sam-
ples of these children have also been studied in a different 
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study on genetic aberrations regarding the Filaggrin-gene 
and SNPs known in allergic diseases [29]. A flowchart 
of the selected samples can be found in Fig.  1. To our 
knowledge no epigenome wide specific power calculator 
is available. Although not fully appropriate, we estimated 
the statistical power of our sample using a power calcu-
lator webtool, originally designed for expression array 
experiments (http://bioinformatics.mdanderson.org/
MicroarraySampleSize). The following thresholds were 
used: Number of genes (25,000); Acceptable number 
of false positives (1); desired fold change (1.3); desired 
power (0.8); standard deviation (0.2). Using these param-
eters a sample size of 14 would be sufficient to detect an 
alpha of 0.00004 per gene.
Epigenetic analysis of selected samples
DNA was isolated from whole blood. Bisulfite treatment 
(ZYMO®) was applied on genomic DNA. DNA-methyl-
ation profiles for each sample were obtained using the 
450K infinium array of Illumina. Raw data was processed 
using standard “genome studio” software of Illumina. 
This processed data was analyzed with statistical analy-
sis scripted in “R” and “Perl”. “R” packages IMA, Minfi, 
wateRmelon, lumi and globaltest were used. We cor-
rected for the two types of probes present on the Illu-
mina array using BMIQ normalization. The presence of 
technical and/or biological batch effects was estimated 
and evaluated by means of principal component analysis 
(PCA). QQ-plots were generated, deflation or inflation 
factor ranging between 0.97 and 1.3 was assumed to be 
acceptable. Relative blood cell distribution was evaluated 
using the Minfi package according the method of House-
man et al. [30]. Standard output of the relative blood cell 
distribution comprises only CD8+ and CD4+ T cells, 
Natural killer cells, B cells, Monocytes and Granulo-
cytes. Since CMA is an immunological disorder, blood 
cell distribution is related to our factor of interest. There-
fore adjustment for blood cell distribution was assumed 
inappropriate. Statistical analysis on individual probe 
differentially methylated positions (DMPs) and on spe-
cific annotated differentially methylated regions (DMR) 
within a gene was performed using IMA package. For 
Dutch EuroPrevall 
Birth Cohort (N=976) 
Children suspected of 
food allergy 
Children suspected of 
CMA (N=91)#)# 
Proven CMA (N=49)# 
CMP tolerant children 





Children with other 







All remaining children 
Fig. 1 Flowchart of samples selected for our epigenetic and phenotypic studies. CMA cow’s milk allergy, N number, #selected for phenotypic factor 
analysis
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association analysis a linear model (limma; default set-
tings) was used. All models were adjusted for age and 
where necessary the model was adjusted for gender. In 
the combined analysis probes representing chromo-
some X and Y were removed from the dataset. Analyses 
were conducted for children with CMA versus control 
children (combined analysis), girls with CMA versus 
control girls (girls), boys with CMA versus control boys 
(boys), and tolerant boys versus control boys (tolerant). 
In order to explore our CMA datasets we evaluated gen-
eral methylation differences. For exclusion of the major-
ity of non-informative probes we used solely probes 
with an unadjusted p  <  0.05 and an absolute methyla-
tion difference >5 % in these analyses. Recent published 
information on the presence of common single nucleo-
tide polymorphism (SNPs) beneath the Illumina 450K 
DNA-methylation probe and specificity of the probe was 
post hoc added to the output using in-house developed 
“Perl” scripts [31]. Common SNPs are especially effective 
confounding in DMPs. For the hypothesis free analysis 
approach we evaluated DMPs and DMRs, for the hypoth-
esis driven analysis approach we extracted all individual 
probes within the candidate gene. Selection of candi-
date genes is described below. Post-hoc SNP evaluation 
was preferred over prior excluding common SNPs from 
the analysis dataset. DMPs were evaluated according the 
adjusted p values (Benjamini–Hochberg), an adjusted 
p value of <0.05 was assumed significant. The annota-
tion of methylation regions used for DMR analysis in the 
IMA package is predefined and thus not based on bio-
logical/statistical correlation between CpGs. Moreover, 
IMA’s adjusted p values are calculated per region. Unfor-
tunately, many of those regions overlap, which results 
seemingly in more independent tests and thus a false 
inflation of the multiple test penalty. In other words, we 
hypothesized that such annotation definition implicated 
more false negative findings per definition. Therefore 
our multiple test correction was based on a Bonferonni 
correction using p value of 0.05 divided by the maxi-
mum amount of genes (i.e. maximum number of genes 
found was 19,500) found in association analyses of this 
study. As such, DMRs were considered significant with 
p < 2.6 × 10−6.
Pathway analysis was performed in the combined, girls 
and boys groups using a global, untargeted, test method 
and the “Gene Ontology” (GO) databases [32]. Probes 
were filtered on the presence of entrez ID annotation. 
Entrez ID covered by less than 3 probes were excluded 
from the analysis. In our enrichment studies we used an 
arbitrary threshold of p < 0.01 in order to evaluate only 
the upper top and unique gene sets. Although enrich-
ment or pathways that are plausible connected to the 
phenotype of interest is favorable, conclusions drawn 
from such analysis have to be taken with much greater 
caution compared to conclusions dawned from results 
like DMP and DMR analyses.
Illumina 450K DNA-methylation array profiles of all 
samples are available on request.
Epigenetic validation procedure
Promising aberrant methylated regions were verified using 
Roche ® 454 Next Generation Sequencing technology. The 
selection of these regions was based on the epigenome 
wide association results (top hits per group), feasible bio-
logical relevancy to CMA of the candidate and availabil-
ity of DNA. Regions in the following genes were evaluated 
using multiple bisulphite primers sets: DHX58, ZNF281, 
EIF42A and HTRA2. Bisulphite primers were designed 
using Methprimer [33]. Primer information is described in 
Additional file 1: Table S1a. Cases and controls were ran-
dom divided over 15 ID sequences, i.e. mids (Additional 
file 1: Table S1b). Concentration of polymerase chain reac-
tions (PCR) fragments was obtained using “Lab on a Chip”. 
Subsequently PCR products were normalized and pooled. 
Sequence reactions were performed conform the Roche 
454 protocol. Raw sequence data was mapped and aligned 
using the AvA software of Roche (Roche, Branford, United 
States). In-house developed scripts (PERL) were used to 
obtain methylation index (β) values for each CG position. 
QC of Roche 454 data was implemented in the script and 
was based on the presence of heterogeneous (non CG or 
TG) polymorphic sites (50 % distribution). Since bisulfite 
pyro sequencing is prone to a T-stretch bias, which may 
result in position shifts of the CG site, careful evaluation of 
flanking positions in the Roche 454 data was implemented 
in the script. Statistical analysis of the methylation index 
was performed in SPSS v20 using a Students T test. Pear-
sons correlation was used to evaluated the CG set within 
every amplicon. P values of correlated CG sites were com-
bined using Fishers method combined p value method, p 
values <0.05 were assumed significant.
Phenotypic differences between several subgroups 
of allergic children
To detect phenotypic differences between genders: fac-
tor analysis was performed. Out of the group of children 
suspected of CMA (N = 91), there were 49 children with 
CMA and 33 children without food allergies. The 20 chil-
dren with CMA who were selected for epigenetic anal-
ysis, were part of the group of 49 children with proven 
CMA (Fig.  1). Phenotypic counts on skin, gastrointesti-
nal, and respiratory symptoms and number of allergies 
in all subsets of patients were investigated. Symptoms 
included in each category have been described previously 
[28]. Number of allergy was defined as more than 1 chal-
lenge proven food allergy.
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Factor analysis for phenotypic differences in all subsets 
of patients were performed by univariate analysis. Factor 
regression coefficients and gender were dependent vari-
ables and age was a covariate. P values <0.05 were con-
sidered significant. SPSS version 20 was used (IBM SPSS 
Statistics for Windows, Armonk, NY).
Hypothesis driven (candidate gene) epigenetic association
Candidate genes were selected from a recent review of 
Bønnelykke et  al. on allergy, sensitization, and related 
atopic disorders [34]. This review discusses previously 
reported genetic associations; mainly GWAS reports, 
with atopic disorders and/or sensitization mechanisms 
of approximately the last decade. We selected in total 66 
genes previously associated with atopic disorders from 
large genome wide studies (GWAS) and 38 genes were 
associated with monogenic allergy related syndromes of 
which 22 genes were located at 22q11.1. 8 selected genes 
were reported for monogenic allergy related syndromes 
as well as GWAS (Additional file 1: Table S2). Individual 
probes were evaluated according the p value (hypoth-
esis free) and adjusted p values based on p value of 0.05 
divided by the maximum amount of genes. Since replica-
tion reports from which we obtained candidates followed 
not the same design and/or platform, we decided to eval-
uate these three reports independently, to overcome a 
too strict multiple test penalty when combining all three 
sets of hits. Therefore we used three separate levels of 
significance. Berni Canani et al. reported about 4 genes, 
Martino et al. reported about 49 genes and the review of 
Bønnelykke et  al. reported about 66 genes, yielding sig-
nificance thresholds of p < 1.25 × 10−2, p < 1.02 × 10−3 
and p < 7.58 × 10−4 respectively.
Results
In Table  1 the patient characteristics of the children 
selected for epigenetic analyses are shown. Controls and 
children with CMA were well matched except for age at 
DNA-sampling, in which children with CMA were sig-
nificantly younger (p  =  0.008) compared to controls. 
Our CMA group consists of both IgE as well as non-IgE 
mediated CMA, with slightly more IgE positive children 
(specific IgE > 0.35 kU/L, p = 0.044) in the CMA group 
compared to controls. Comparison of the 10 tolerant 
boys with 10 control boys, shows no significant differ-
ence in age at DNA-sampling (p =  0.71) nor IgE status 
(p = 0.56), but did show a significant difference in mater-
nal folic acid use during pregnancy (p  =  0.012), with 
more folic acid use in the control group.
Epigenetic 450K analysis of selected samples
All 450K analysed samples passed quality control. PCA 
showed no evidence of confounding technical batch 
effects according array or array-position (data not 
shown).General DNA-methylation analysis showed 
a hypermethylation in the CMA group. While in the 
Fig. 2 Percentage hyper and hypomethylated probes in cow’s milk allergy (CMA) patients versus controls. Filtering was based on a p value <0.05 
and an absolute DNA-methylation difference (delta β values) >5 %; boy*: group boys who had CMA, but are now tolerant
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tolerant boys versus controls we observed no deviation of 
the expected ratio hyper/hypomethylation (i.e. 50/50 %) 
(Fig. 2). A good concordance between CMA-children and 
controls with regard to the mean relative distribution of 
different types of, only the most abundant, blood cells: 
CD8+ and CD4+ T cells, natural Killer, B lymphocytes, 
monocytes and granulocytes was found (Additional file 2: 
Figure S1). Furthermore, the variation among blood 
cell type between groups (expressed as standard devia-
tion) was not different. Relative cell distribution was not 
included as covariate in further analysis.
Top 5 hits for DMP’s between CMA and controls for all 
analysed groups are presented in Table 2. None of indi-
vidual probes reached genome wide significance. Table 3 
shows DMR’s that were found to be associated in more 
than one group (combined, girls and boys) with a delta 
methylation difference >0.01. In total ten regions, with 
their respective gene, were found. Additional file 1: Table 
S3a–c describes all DMR top 5 hits in each analysed 
group regardless of the methylation difference (delta). 
We observed no overlap in loci between boys and 
girls. The locus ZNF281 was found to be hypermethyl-
ated significantly in the boys analysis (p  =  1.3  ×  10−6, 
delta = 0.034). The remaining 9 loci showed nominal sig-
nificant methylation differences and included OR5M8, 
KIAA1324L, EIF4E2, HTR2A, ZNF366, DHX58, PRB4, 
DNM1 and WNT10A (Table 3). Although these loci were 
good candidates for validation procedures, the availabil-
ity of sufficient DNA was a strong limiting factor. There-
fore only four candidate loci were selected for validation. 
The following four genes were selected for validation: (1) 
ZNF281; involved in the transcriptional regulation of sev-
eral interesting genes like GAST, (2) EIF4E2; involved in 
the interferon pathway, (3) HTR2A; involved in smooth 
muscle contraction and aldosterone production and (4) 
Table 1 Characteristics of Dutch allergy study population; cow’s milk allergy versus controls
Significant p-values <0.05 are in italic
NA not applicable, CMA cow’s milk allergy, p p value, SD standard deviation, N number, CMP cow’s milk protein
a Pearson Chi square test
b Age in months ANOVA
c Fisher’s exact test, 2-sided
d Pearson Chi square test for trend
CMA Controls p Tolerant Tolerant control boys p
N (♀)a 20 (8) 20 (10) 0.342 10 (0) 13 (0) NA
Age diagnosis CMA ± SDb 6.5 ± 2.5 NA NA 5.8 ± 2.2 NA NA
Age at sampling ± SDb 11.8 ± 4.8 17.2 ± 7.1 0.008 18.0 ± 5.5 17.2 ± 4.3 0.714
N of children with CMP sIgE > 0.35 kU/Lc 7 1 0.044 2 1 0.560
Mean CMP sIgE value ± SD (kU/L) 1.15 ± 3.6 0.16 ± 0.64 0.260 0.19 ± 0.39 0.23 ± 0.79 0.693
Range CMP sIgE value (kU/L) 16.4 2.9 NA 1.0 2.9 NA
Maternal smokingd 0.659 0.483
 Pregnancy 2 3 1 2
 Before pregnancy 5 5 2 4
 Never 13 12 7 7
Maternal vitamin Dd 0.317 NA
 Regular 0 0 0 0
 Period only 0 0 0 0
 Irregular 1 0 0 0
 None 19 20 10 13
Maternal multivitamind 0.836 0.883
 Regular 12 11 1 5
 Period only 2 2 4 3
 Irregular 1 1 0 0
 None 5 6 5 5
Maternal folic acidd 0.656 0.012
 Regular 8 9 0 5
 Period only 9 9 10 6
 Irregular 1 0 0 0
 None 2 2 0 2
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DHX58; involved in the innate immune response to RNA 
and DNA (viruses).
Pathway evaluation of 450K data of selected samples
Biological Process pathways, i.e. GO terms, with a nomi-
nal p value <0.01 were evaluated in the combined, girls 
and boys analysis according to a global, untargeted, test 
method. Entrez IDs covered by less than 3 probes were 
excluded from the analysis. We selected enrichment of 
GO terms representing a unique set of genes in combina-
tion with the number of contributing probe sets within 
that GO annotation. This way similar defined pathways 
but with different GO annotation were removed from 
the datasets. We hypothesized that GO terms involved in 
immunological, epithelial and respiratory classes are fea-
sible to be involved in CMA. Therefore, we applied such 
class annotation to the detected GO terms. Figure 3 illus-
trates the relative percentage of the three classes within 
the filtered global test analysis in the combined, girls and 
boys groups. Specific GO term annotations are described 
in Additional file 1: Table S4.
The majority of detected pathways in the combined 
group involved immunological pathways (20  %), epithe-
lial (4  %) and respiratory (2  %) pathways. In girls, only 
immunological pathways were detected (20 %). Boys on 
the other hand, showed in addition to immunological 
GO terms (23.5 %), epithelial related GO terms (5.9 %) as 
well. Interestingly, GO terms showed virtual no overlap 
between combined and girls or between girls and boys, 
while immunological terms between combined and boys 
suggests overlap in GO terms involved in epithelial cell 
polarity and immunological pathways.
Validation of 450K results
Validation for the following candidate regions was per-
formed: ZNF281, EIF4E2, HTR2A and DHX58. Associa-
tion values of the DMRs of these four genes are described 
in Table 3. Bisulphite primer sets were designed overlap-
ping or near the CpG extension site of (nominal) signifi-
cant found 450K probes. In total we designed 12 different 
amplicons for the four loci. For ZNF281 we were able to 
successfully optimize two amplicons, for EIF4E2 and 
HTR2A one amplicon and for DHX58 three amplicons. 
The exact chromosomal position (HG19) of covered CpGs 
as well as successful primer sequences are described in 
Additional file  1: Table S1a. PCR optimization was per-
formed using a standard annealing temperature gradi-
ent protocol. 454 Sequencing preparation of the library 
was conform the Roche manual. Indices are presented in 
Additional file  1: Table S1b. The 450K DNA-methylation 
array data showed for several candidates methylation lev-
els close to 10 or 90 %. The latter implies a lower reliabil-
ity of the quantitative level of DNA methylation in case 
of a next generation sequencing (NGS) read count below 
Table 2 Top 5 differential methylated positions (DMPs) in combined, girls and boys analysis
p p value, adj. p adjusted p value (BH), Delta expressed as β difference, IGR inter genic region, 5′-UTR 5′ untranslated region, Body genebody, TSS1500 transcription 
start site 1500 bp upstream
a High frequency (CEU MAF > 0.05) SNP located at position 34 of probe. Adjusted p values <0.05 were assumed significant
Probe p Adj. p Delta Gene Region
Combined
 cg07687119 6.4E−06 0.942 0.009 HOXC4/5/6 5UTR/body/
body
 cg01599189 1.1E−05 0.942 0.020 NBPF1 5′UTR
 cg09789536 2.8E−05 0.942 0.020 KLHL17 Body
 cg11433629 2.9E−05 0.942 −0.012 IGR NA
 cg23339709 2.9E−05 0.942 0.009 OR8U8/OR5M8 Body/exon1
Girls
 cg23876832a 1.7E−07 0.081 0.214 IGR NA
 cg13181291 1.8E−06 0.427 −0.016 GABPB2 Body
 cg13700939 1.3E−05 0.999 0.065 IGR NA
 cg09573389 1.3E−05 0.999 0.039 C10orf58 TSS1500
 cg24691332 3.0E−05 0.999 0.024 PARD3 Body
Boys
 cg06644124 1.6E−06 0.773 0.034 ZNF281 1stExon/5UTR
 cg11126313 1.2E−05 0.997 0.009 CCR3 5UTR
 cg09357684 1.4E−05 0.997 0.064 THAP3 TSS1500
 cg09175834 1.5E−05 0.997 0.018 NAV3 1stExon
 cg21255128 2.1E−05 0.997 0.018 C7orf50 Body
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500. Therefore we aimed for an average depth of 1000 
reads. Amplicon 2 and 3 of the ZNF281 gene covered the 
450K cg26678649 and cg09255666 probes and the flank-
ing cg24347950 and cg0644124 probes. Unfortunately 
the average methylation index of the amplicon CpGs did 
not correspond with the 450K array data, indicating a 
failed validation for the 450K array ZNF281 region data 
(Additional file  3: Figure S2A). The second amplicon for 
the EIF4E2 region flanked the 450K cg10364945 probe. 
Although the methylation pattern of the CpGs present in 
this amplicon were concordant to the 450K data we did 
not observe a similar methylation variation between girl 
CMA cases and girl controls (Additional file 3: Figure S2B). 
For the HTR2A region one amplicon was successfully opti-
mized, covering in total 6 CpG positions of which 5 cov-
ered the 450K probes cg20102280 (47470793), cg15894389 
(47470857), cg02250787 (47470989),cg06476131 
(47471052) and cg06476131 (47471090). The first CpG 
sites located at position 47470760, 47470793, 47470857 
showed high correlation and showed a significant 
hypermethylation (p =  5.1E−4) in CMA patients (Addi-
tional file  3: Figure S2C). The first DHX58 amplicon, 
showed a concordant DNA-methylation pattern with the 
upstream flanking the probe cg08577293 and the down-
stream flanking probe cg01405890 covered in total 4 CpG 
sites. In line with the 450K data, the NGS data showed sig-
nificant hypomethylation in CMA boys compared to con-
trols (p = 1.1E−3). In CMA girls hypomethylation at this 
position was absent. The second DHX58 amplicon covered 
in total 22 CpG sites covering and flanking the 450K probe 
cg02450064 (40260053). Although, the NGS obtained 
methylation index of this CpG site showed moderate rep-
lication with regard to the 450K data, an interesting and 
highly significant hypomethylation was observed upstream 
of cg02450064 (40260053) in CMA boys (p  =  9.8E−06) 
and CMA girls (p  =  2.8E−06) compared to controls 
(Additional file 3: Figure S2D). The third DHX58 amplicon 
showed insignificant but concordant methylation indices 
(0–5 %) compared to the 450K data (Additional file 3: Fig-
ure S2D).
Table 3 Selection of most significant differential methylated regions found in >1 group with delta >0.01
a Nearest gene; for genomic regions concerning ISLAND, NSHORE, SSHORE, NSHELF and SSHELF, UCSC browser was used to determine the nearest gene
b Val validated using Roche 454 sequencing
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Gender differences
Epigenetic results show clear differences between CMA 
boys and girls with respect to their controls with hardly 
any overlap in obtained loci between the groups, as 
shown in Tables 2, 3, Fig. 3, and Additional file 1: Table 
S3. Although such gender difference, even with exclusion 
of the X and Y-chromosomes is a common phenomenon 
in epigenetics, we evaluated whether such difference is 
also phenotypically present. A factor-analysis on pheno-
typic CMA characteristics of all 91 children suspected of 
CMA, showed a difference in the univariate analysis with 
gender as independent factor (p =  0.05). The same fac-
tor-analysis model in the children selected for epigenetic 
analyses showed no difference in the univariate analysis 
with gender as independent factor (Tables  4, 5). Fur-
thermore, there were more boys compared to girls with 
proven CMA (Table 4).
Hypothesis driven epigenetic association
For the candidate gene association studies we evalu-
ated findings of three recent published reports with our 
dataset. First was the report of Berni Canani et  al. on 
DNA methylation differences of IL-4, IL-5, IL-10, and 
INF-γ in IgE mediated CMA patients [35]. We did not 
detect any replication in any of the reported loci (data 
not shown) applying a multiple test significance level of 
p < 1.25 × 10−2 (Bonferonni, 0.05/4 independent tests). 
Second was the report of Martino et al. epigenome wide 
association in IgE mediated food allergy [36]. In total 
2281 probes were extracted from our dataset. The six 
lowest p values (p < 0.005) covered 1 probe at GALNTL4, 
2 probes at HDAC4 locus, 1 probe at KCNN3 locus and 
2 probes at the RPS6KA2 locus (data not shown). How-
ever, we cannot claim replication for any of the probes 
annotated for the 49 reported genes (p  <  1.02  ×  10−3, 
Bonferonni, 0.05/49 independent tests). The final hypoth-
esis driven evaluation was based on a review on genetic 
rather than epigenetic association studies of atopic dis-
eases by Bønnelykke et  al. [34]. In total we selected 66 
genes covered by approximately 1650 individual probes 
(Additional file  1: Table S2a). We found one significant 
replication applying a multiple test significance level 
of p  <  7.58  ×  10−4 (Bonferonni, 0.05/66 independent 
tests). The probe cg03990811, located in the MICA gene 
showed significant association (p  =  3.9  ×  10−4) in the 
combined analysis (Additional file  1: Table S4b). This 
finding is strengthened by the fact that we found a sec-
ond probe (cg14462939, p =  3.9 ×  10−3) present in the 
top5 hits and located in the MICA gene (Additional file 1: 
Table S2b).
Fig. 3 Global test and gene set enrichment analysis in CMA patients versus controls according GO terms. Y-axis contribution (%) of CMA related 
pathways, i.e. immunological, respiratory and epithelium related
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Discussion
In this pilot study we aimed to detect DNA-methylation 
differences between a group of mixed gender CMA and 
healthy controls. Several differential methylated loci were 
found, suggesting aberrant DNA-methylation is involved 
in the expression of CMA. Additional DNA-methylation 
analysis between a group of CMA tolerant boys and con-
trols showed no DNA-methylation differences at all. We 
validate three loci of the top 10 of the 450K array results 
using bisulphite amplicon NGS. We found no evidence of 
confounding effects of inoculation or differences of blood 
cell distribution between cases and controls. Epigenetic 
gender differences were not reflected in a phenotypic 
symptom pattern in the CMA group but were present in 
the better-powered total allergy cohort.
Epigenetic results
Although it is a topic of high interest, we are the second 
to describe an epigenetic survey in children with CMA 
[14, 35]. General hypermethylation was found in children 
with CMA, which disappeared after developing toler-
ance. In addition a difference in methylation between 
boys with CMA and control boys was found in this study. 
Hypermethylation in general is associated with repressed 
gene transcription [37]. In case a repressed gene codes 
for a transcription factor, several of its target genes might 
show an excess of expression. In CMA the immune sys-
tem is overactive, suggesting immunological suppressive 
genes should be hypermethylated in general, compared 
to non-CMA children [38]. In CMA tolerant children 
this hypermethylation effect completely disappeared. 
Therefore, hypermethylation can only serve as biomarker 
during the allergic state.
DMR analysis showed several feasible genes to be 
involved in CMA. ZNF281 was significantly hypermeth-
ylated in boys versus controls. This gene is a transcrip-
tional regulator, known to repress several genes, for 
example GAST (located on chromosome 17) [39]. GAST 
is known to stimulate the stomach mucosa, produc-
tion of digestive enzymes, smooth muscle contraction 
and releases histamines. Therefore hypermethylation of 
ZNF281 might be related to the gastro-intestinal symp-
toms in children with CMA. However, since the NGS 
amplicon analysis showed disconcordant and different 
methylation levels in CMA patients and controls, the 
claim of significance of the 450K results for the ZNF281 
locus has to be taken with caution.
EIF4E2 is primarily involved in the initiation of pro-
tein synthesis [39]. Melnik et  al. reported about the 
importance of breastmilk in early development and 
the mTORC1 signaling pathway. The EIF4 protein fam-
ily plays a key role in this pathway that stimulates (post 
natal) growth and can be regulated by maternal excreted 
exosomal miRNAs [40]. Our finding of hypomethylation 
of EIF4E2 might be the result of absence of these mater-
nal miRNAs due to CMP free diet. Dysregulation of the 
mTORC1 pathway might be related to the methylation 
status of EIF4E2.
Hypermethylation of HTR2A is likely related to less 
expressed protein and might on turn be related to 
Table 4 Characteristics Subsets Dutch allergy study population
SD standard deviation, FA food allergy, CMA cow’s milk allergy, CMA-subset 20 children selected for epigenetic analysis from the total group of children with proven 
CMA, GI gastrointestinal, Resp respiratory
Subset N (%♀) Mean age ± SD 
(months)
Phenotype counts (%) Allergies (>1)
Skin GI Resp
Suspicion of CMA allergy 91 (37.4) 36.2 ± 10.6 68 (55.7) 47 (38.5) 7 (5.7) 14
CMA 49 (36.7) 28.9 ± 13.7 35 (53.0) 27 (40.9) 4 (6.1) 7
CMA-subset 20 (40.0) 28.6 ± 11.4 15 (51.7) 11 (37.9) 3 (10.3) 7
FA 58 (34.5) 30.7 ± 14.2 44 (56.4) 29 (37.2) 5 (6.4) 14
No FA 33 (42.4) 45.9 ± 26.2 24 (54.5) 18 (40.9) 2 (4.5) 0
Table 5 Association of gender with factor analysis regres-
sion coefficients
FA food allergy, CMA cow’s milk allergy, GI gastrointestinal, Resp respiratory
a Factor analysis, extraction of components: eigenvalue >1
b Univariate model: independent: gender, dependent: Regression coefficient 
factor analysis, covariate: age
c Reported p value for gender
Subset componentsa Skin GI Resp FAb p valuec
Allergy (C1 of 2) 0.85 −0.81 0.37 −0.02 0.051
Allergy (C2 of 2) 0.07 −0.18 −0.52 0.85 0.702
No FA (C1 of 2) −0.73 0.85 0.20 0.49 0.794
No FA (C2 of 2) 0.51 0.15 0.91 0.12 0.292
FA (C1 of 2) 0.81 −0.82 0.47 0.26 0.284
FA (C2 of 2) 0.12 −0.02 −0.54 0.85 0.249
CMA (C1 of 2) 0.81 −0.81 0.52 −0.20 0.324
CMA (C2 of 2) 0.22 −0.20 −0.29 0.91 0.107
CMA-DNA (C1 of 2) 0.83 −0.86 0.30 0.51 0.843
CMA-DNA (C2 of 2) 0.16 0.02 0.85 −0.72 0.213
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gastro-intestinal symptoms in CMA patients via altered 
intestinal muscle contraction [39]. The methylation pat-
tern of the bsr amplicon NGS was similar to the 450K 
although we observed a consistent lower methylation 
index in the NGS data.
Although, not significantly associated according to the 
applied multiple test threshold, DHX58 showed robust 
variability in all analyses including NGS bsr amplicon 
validation. The protein encoded by this gene plays a cru-
cial step at the beginning of the cascade of antigen rec-
ognition in the innate immune response to various RNA 
viruses and some DNA viruses. Hypomethylation of 
DHX58 might lead to over expression of this gene, which 
on turn might favour viral nucleoprotein recognition by 
DDX58/RIG-I and IFIH1/MDA5 complexes [39]. Deretic 
et al. proposed that nutritional signals (mTORC pathway) 
and immune signalling (RIG-I/MDA5 pathway) might 
stimulate similar cascades. This suggestion might indi-
cated that our findings on EIF4E2 and DHX58 underlie 
similar and maybe shared cascades [41]. Future studies 
should therefore investigate whether cow’s milk proteins 
are capable of mimicking epitopes, confirming a role of 
DHX58 in CMA.
Other genes in the top 5 findings are interesting as well. 
Unfortunately, the availability of DNA in these CMA 
samples was limited which disabled validation of fur-
ther loci. Feasible biological relevance and their possible 
involvement in CMA have to be studied further.
Pathway evaluation of 450K data of selected samples
Gene set enrichment analyses based on a global test 
method, suggest that specific immunological mecha-
nisms are involved in CMA. Interestingly, no overlap of 
these pathways between combined and girls or girls and 
boys were observed, suggesting involvement of differ-
ent immunological biological processes between boys 
and girls with CMA (Additional file 1: Table S4a; Fig. 3). 
However, limited statistical power cannot be excluded as 
cause of this difference between genders. We did observe 
gender differences with regard to other, non-immunolog-
ical, biological processes. A limited number of biological 
processes suggests involvement of epithelium develop-
ment in combined CMA and boys CMA only. Further-
more, biological processes involved in the respiratory 
mechanism, was solely observed in boys. We can state 
that our results strongly suggest involvement of gender 
specific immunological processes and that other pro-
cesses prone to be involved in CMA, are likely to be dif-
ferent between genders as well.
Gender difference
In this study we observed a clear difference, or in other 
words no overlap, of aberrant methylation loci, between 
boys and girls. These results were found in the differ-
ences in top-hits in the epigenetic results, but also in the 
number of boys with CMA and in the factor-analysis of 
all children suspected of CMA. This implies that different 
biological mechanisms underlie CMA in boys and girls. 
However we were not able to confirm this difference in 
the factor-analysis in our subgroup of 20 CMA-children 
and 20 controls. This is probably due to very small sub-
groups in a very heterogeneous disease. Furthermore 
symptom descriptions, obtained through questionnaires 
answered by parents are very subjective, compared to 
epigenetic results. It is very likely that these effects are 
smaller in larger sample sizes. However, differences 
between boys and girls are not unexpected. It has been 
described both, in allergy studies, as well as in epigenetic 
studies [21–24].
Allergic march
The epigenetic results presented in this study, show 
methylation differences in children suffering from CMA 
relative to controls, which disappears in the children who 
developed tolerance to CMA.
So far, it has been considered that children who suf-
fer from FA, are at risk of developing other allergic dis-
eases later in life [42]. However, since the methylation 
differences found in our study disappear upon develop-
ing CMP tolerance, there is no indication that the stud-
ied loci are involved in development of the allergic march 
in children with CMA, despite some (top hit) loci have 
been described in childhood asthma as well [39]. A recent 
review discussed the short-term dynamics of epigenetic 
programming within human immunological responses. 
They stated that epigenetic regulation plays a key role in 
proliferation and differentiation of specific immune sys-
tems. Immune cells share for example many specific tran-
scription factors, but remodelling of the epigenome is 
thought to be essential regulating specific gene expression 
profiles for different lineages [43]. Since our data suggest 
the absence of CMA “epigenetic memory” or evidence 
of certain enrichment of specific immune cells, it may 
disprove the hypothesis arguing for an epigenetic basis 
underlying the “allergic march”. Literature on the develop-
ment of the allergic march is contradicting, with studies 
reporting on the development of the allergic march, as 
well as studies describing a co-manifestation instead of 
an allergic march [9, 42, 44, 45]. An epigenetic risk pro-
file might also be a contributing factor. Since methylation 
can change back and forth more than once in life, cer-
tain people might be more at risk for expressing diseases 
involved by epigenetic changes. However, our results 
need to be interpreted with great caution, with a very lit-
tle sample size in a heterogeneous disease. Furthermore, 
these results are based on CMA and CMP-tolerance 
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development only, clinical data regarding development of 
other allergic diseases in life are not yet available, due to 
the prospective character of this study. It would be inter-
esting to evaluate these children in the future in case of 
the development of other allergic diseases.
Replication other reports involving CMA
Although no significant replication was found with the 
review of Bønnelykke et al., according the q value based 
on the number of selected probes, applying a multiple 
test correction based on the number of genes, showed 
significant replication for the MICA gene [34]. In addi-
tion, this finding is strengthened by the fact that another 
probe located in this gene was present in the DMP top 5 
hits. According UCSC public databases, both probes are 
located in the first intron of the MICA gene which, also 
represents a strong H3K27AC mark that is associated 
with an active regulatory element [46]. MICA is closely 
positioned to HLA-B and C on chromosome 6, which 
both are thought to play an important role in MHC inter-
actions and immune related disorders. MICA itself codes 
for a protein that functions as a stress-induced antigen. 
Interestingly, MICA is broadly recognized by intestinal 
epithelial gamma delta T cells, favouring an association 
with FA.
We were not able to replicate the results of two other 
studies on epigenetics in food allergy studies [34, 35]. Dif-
ferences in the design between our study and the studies 
of others are likely to be responsible for the absence of 
replication. First of all, we used whole blood sample anal-
yses, while both other studies used subsets of blood cells, 
namely peripheral blood mononuclear cells and CD4+ 
T cell respectively. Second, we studied children with IgE 
and non-IgE mediated CMA, while Berni Canani et  al. 
studied children with CMA with high levels of IgE only 
and Martino et  al. studied children with IgE-mediated 
FA, and included only one child with CMA. Further-
more the study of Berni Canani et  al. used a candidate 
gene approach. The study of Martino et  al. was based 
on a pooled sample strategy and analysis was based on 
a mixed gender design [34, 35]. Our analysis was untar-
geted and we have followed both a combined and gender 
stratified strategy. This emphasizes the importance and 
the great bias potential of epigenetic, tissue related, het-
erogeneity which is very likely to block positive replica-
tion between studies.
Strength and weaknesses of the study
The main strength of the studied samples is that CMA is 
diagnosed according to the current available gold stand-
ard [27]. Furthermore, clinical data are well documented 
due to the setup of the study with regular questionnaires 
[25].
Since our sample size is small, we used strict thresholds 
for evaluation of our results. For p values this threshold 
was based on bonferonni and for effect size we applied 
an absolute difference of >5 %. Despite these thresholds 
results need to be interpreted with great caution, until 
they are replicated in an independent study.
Our sample involves IgE and non-IgE mediated CMA 
cases. Additional analysis of epigenetic profiles of CMA 
patients with relative high levels of IgE (N = 12 combined 
genders, IgE ranging between 0.01 and 16.4, three CMA 
cases IgE  >  0.5) showed no additional significant hits 
with regard to the total group of CMA children (data not 
shown). In general the IgE plasma level is not an essen-
tial parameter in CMA diagnosis. Moreover, IgE medi-
ated and non-IgE mediated CMA might origin from an 
overlapping or similar sensitization mechanism [43]. Our 
study is thus limited in the sense that we solely are able 
to detect general CMA associated epigenetic loci. Future 
research using a larger CMA sample should include IgE 
and non-IgE stratified analyses. Ideally these IgE meas-
urements should be measured several times during the 
course of disease.
Unfortunately, there was only one DNA-sample avail-
able per child. Therefore, comparisons over time within 
the same child were not possible. Also, it was not possi-
ble to obtain DNA-samples in all children. Furthermore 
the amount of blood drawing for research purposes in 
infants is in the Netherlands limited to 2.5 mL. The latter 
also implies that a sufficient DNA yield in DNA extrac-
tion of a specific blood cell is virtual impossible.
Proper meta-analysis nor replication of our findings in 
an independent well characterized CMA cohort unfortu-
nately appeared not to be feasible. Previous reports gen-
erally are based on specific immune cells while our study 
is based on DNA obtained from whole blood. Validation 
our dataset was therefore solely based on replicating 
findings of others in our sample.
In general, discrepancy between the NGS and 450K 
methylation index might be the result of a failing normal-
ization procedure (BMIQ) to overcome the probe bias 
of the array. A suboptimal primerset, in case of ampli-
con NGS, cannot be excluded as another cause of the 
discrepancy.
The national Dutch vaccination program is extensive 
and starts already at young age. Since vaccination can 
have a major impact on the blood cell distribution and/
or on methylation status of particular loci we preselected 
our sample and evaluated post hoc the period between 
vaccination and blood drawing (Additional file 4: Figure 
S3). We excluded all children who received a vaccination 
up to 4 weeks prior to DNA-sampling [47]. Since no sig-
nificant differences between CMA cases and controls and 
their period (>4  weeks) between vaccination and blood 
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drawing were found, we are confident vaccination plays 
an insignificant role with regard to the epigenetic aber-
rations we detected in this study. Finally there is a statis-
tical significant difference in the folic acid consumption 
of mothers during pregnancy between the tolerant boys 
and control boys. It is known that folic acid has the abil-
ity to influence epigenetics. Since our sample size is very 
limited, folic acid is widely used by pregnant women and 
this difference was only found between already tolerant 
boys and controls (and not in children still suffering from 
CMA), we consider the relevance of this difference lim-
ited [48–50].
Future studies
The present study should be classified as pilot study or 
proof of principle study. Moreover, CMA can be charac-
terized as a complex disease involving multiple loci and 
a heterogeneous phenotype. Thus, in combination with 
the fact we analysed only relative small groups, further 
studies in larger cohorts are essential in order to replicate 
or validate our findings. Ideally, sample size in this study 
would be large enough to investigate boys and girls as 
well as IgE and non-IgE mediated CMA separately or to 
perform subgroup-analysis.
To investigate whether there is a evidence for the aller-
gic march, it would be interesting to compare epigenetic 
analyses during infancy, school-age and later life. Boys 
and girls should be separately analysed to also investigate 
a gender effect.
Since infants develop CMA at a very young age. Diet 
is known to be involved in the development of certain 
diseases, probably through epigenetic alterations, in the 
next generations [51]. And milk is known to influence the 
infants immune system [40, 52]. It would be very inter-
esting to investigate the role of (breast)milk in a future 
epigenetic study in children with cow’s milk allergy, espe-
cially seen our findings in EIF4E2.
Conclusion
Current studies indicate the involvement of epigenetic 
mechanisms underlying the expression of CMA. In par-
ticular DHX58, involved in DDX58/RIG-I and IFIH1/
MDA5 immunological pathways, are involved in CMA in 
young boys, while in CMA girls EIF4E2, HTR2A seems to 
play a role. Our data strongly suggests a different mech-
anism for girls and boys underlying CMA. We have no 
indication DNA methylation aberrations play a crucial 
role in the allergic march, since all effects disappeared 
upon developing CMA tolerance in boys. However, due 
to small sample size further studies are necessary before 
definite conclusions can be drawn.
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